Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:48:59 UTC |
---|
HMDB ID | HMDB0000037 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Aldosterone |
---|
Description | Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically, it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine. |
---|
Structure | [H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+)-Aldosterone | ChEBI | (11beta)-11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al | ChEBI | 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al | ChEBI | (11b)-11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al | Generator | (11Β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al | Generator | 11b,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al | Generator | 11Β,21-dihydroxy-3,20-dioxo-4-pregnen-18-al | Generator | Aldosterone, (+-)-isomer | HMDB | Aldosterone, (11 beta,17 alpha)-isomer | HMDB | 11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al | HMDB | 11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al | HMDB | 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione | HMDB | 11Β,21-dihydroxy-3,20-diketo-4-pregnen-18-al | HMDB | 11Β,21-dihydroxy-3,20-diketopregn-4-ene-18-al | HMDB | 11Β,21-dihydroxypregn-4-ene-3,18,20-trione | HMDB | 18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione | HMDB | 18-Formyl-11β,21-dihydroxy-4-pregnene-3,20-dione | HMDB | 18-Oxocorticosterone | HMDB | Aldosterone | HMDB |
|
---|
Chemical Formula | C21H28O5 |
---|
Average Molecular Weight | 360.444 |
---|
Monoisotopic Molecular Weight | 360.193674006 |
---|
IUPAC Name | (1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde |
---|
Traditional Name | (1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde |
---|
CAS Registry Number | 52-39-1 |
---|
SMILES | [H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O |
---|
InChI Identifier | InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1 |
---|
InChI Key | PQSUYGKTWSAVDQ-ZVIOFETBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Hydroxysteroids |
---|
Direct Parent | 21-hydroxysteroids |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 21-hydroxysteroid
- 20-oxosteroid
- Pregnane-skeleton
- 18-oxosteroid
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- Oxosteroid
- 11-beta-hydroxysteroid
- 11-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Alpha-hydroxy ketone
- Ketone
- Secondary alcohol
- Cyclic ketone
- Alcohol
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Primary alcohol
- Aldehyde
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 166.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.051 mg/mL at 37 °C | Not Available | LogP | 1.08 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Aldosterone,1TMS,isomer #1 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 3323.3 | Semi standard non polar | 33892256 | Aldosterone,1TMS,isomer #2 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12 | 3274.4 | Semi standard non polar | 33892256 | Aldosterone,1TMS,isomer #3 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C)CC[C@@H]12 | 3325.9 | Semi standard non polar | 33892256 | Aldosterone,1TMS,isomer #4 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 3268.7 | Semi standard non polar | 33892256 | Aldosterone,1TMS,isomer #5 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12 | 3262.2 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #1 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 3249.5 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #2 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3315.5 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #3 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 3227.5 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #4 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3311.0 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #5 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C)CC[C@@H]12 | 3212.7 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #6 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12 | 3165.5 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #7 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 3168.5 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #8 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C)CC[C@@H]12 | 3249.5 | Semi standard non polar | 33892256 | Aldosterone,2TMS,isomer #9 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 3168.3 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #1 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3221.4 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #1 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3228.2 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #1 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3766.4 | Standard polar | 33892256 | Aldosterone,3TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 3150.3 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 3273.7 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 3772.8 | Standard polar | 33892256 | Aldosterone,3TMS,isomer #3 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3248.1 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #3 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3169.3 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #3 | C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3786.0 | Standard polar | 33892256 | Aldosterone,3TMS,isomer #4 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3221.0 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #4 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3355.2 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #4 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3801.0 | Standard polar | 33892256 | Aldosterone,3TMS,isomer #5 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3198.9 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #5 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3324.2 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #5 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3817.7 | Standard polar | 33892256 | Aldosterone,3TMS,isomer #6 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C)CC[C@@H]12 | 3113.4 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #6 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C)CC[C@@H]12 | 3255.7 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #6 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C)CC[C@@H]12 | 3809.3 | Standard polar | 33892256 | Aldosterone,3TMS,isomer #7 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 3061.4 | Semi standard non polar | 33892256 | Aldosterone,3TMS,isomer #7 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 3209.2 | Standard non polar | 33892256 | Aldosterone,3TMS,isomer #7 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 3839.5 | Standard polar | 33892256 | Aldosterone,4TMS,isomer #1 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3113.5 | Semi standard non polar | 33892256 | Aldosterone,4TMS,isomer #1 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3340.5 | Standard non polar | 33892256 | Aldosterone,4TMS,isomer #1 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)C(=C(CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3662.8 | Standard polar | 33892256 | Aldosterone,4TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3144.6 | Semi standard non polar | 33892256 | Aldosterone,4TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3281.7 | Standard non polar | 33892256 | Aldosterone,4TMS,isomer #2 | C[C@]12CC=C(O[Si](C)(C)C)C=C1CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C)C[C@]2(C=O)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3719.6 | Standard polar | 33892256 | Aldosterone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3625.0 | Semi standard non polar | 33892256 | Aldosterone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@H]2[C@@H]2CCC3=CC(=O)CC[C@]3(C)[C@@H]12 | 3520.8 | Semi standard non polar | 33892256 | Aldosterone,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(CO)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3607.9 | Semi standard non polar | 33892256 | Aldosterone,1TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC(=CO)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3505.9 | Semi standard non polar | 33892256 | Aldosterone,1TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12 | 3511.8 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3771.3 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3856.6 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3801.0 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3734.7 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC(CO)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3728.3 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC(=CO)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3638.5 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12 | 3614.4 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #8 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3745.0 | Semi standard non polar | 33892256 | Aldosterone,2TBDMS,isomer #9 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3637.0 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3925.9 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3907.7 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3978.6 | Standard polar | 33892256 | Aldosterone,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3921.8 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3826.7 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3996.6 | Standard polar | 33892256 | Aldosterone,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3831.9 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3834.9 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3982.5 | Standard polar | 33892256 | Aldosterone,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3942.5 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3910.7 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 4028.6 | Standard polar | 33892256 | Aldosterone,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3879.0 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 3841.3 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C=O | 4059.8 | Standard polar | 33892256 | Aldosterone,3TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3795.0 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3798.3 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)C(=C(CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 4036.5 | Standard polar | 33892256 | Aldosterone,3TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3743.2 | Semi standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3743.2 | Standard non polar | 33892256 | Aldosterone,3TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1)CC[C@@H]1[C@@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]2(C=O)[C@@H](C(=CO)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 4060.3 | Standard polar | 33892256 | Aldosterone,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3953.6 | Semi standard non polar | 33892256 | Aldosterone,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 4020.6 | Standard non polar | 33892256 | Aldosterone,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3884.6 | Standard polar | 33892256 | Aldosterone,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3971.8 | Semi standard non polar | 33892256 | Aldosterone,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3949.4 | Standard non polar | 33892256 | Aldosterone,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@@H](O[Si](C)(C)C(C)(C)C)C[C@]12C=O | 3924.4 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Aldosterone EI-B (Non-derivatized) | splash10-06si-0694000000-60e1d35ad11d153b5152 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_1_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aldosterone GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone LC-ESI-qTof , Positive-QTOF | splash10-0596-2961000000-38453356e63a34116d1e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone , positive-QTOF | splash10-0596-2961000000-38453356e63a34116d1e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 20V, Positive-QTOF | splash10-00te-0795000000-8d98d67da0a192149a61 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 50V, Positive-QTOF | splash10-00dj-0930000000-9939fdefed4cc5aa1223 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 40V, Positive-QTOF | splash10-00dj-0940000000-75f24824d5d69e3323b5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 50V, Positive-QTOF | splash10-00dj-0930000000-f7fdb389785258ecb726 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 20V, Positive-QTOF | splash10-00te-0795000000-21a3474f31fec88ef12b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 10V, Positive-QTOF | splash10-01ox-0019000000-cd366dadcc06e9631cd2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 30V, Positive-QTOF | splash10-00dj-0960000000-b9db4295ff8d4a972819 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aldosterone 40V, Positive-QTOF | splash10-00dj-0940000000-f4e29f9da2ae7127e9e5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 10V, Positive-QTOF | splash10-01ox-0019000000-2c34b91dc8d5030ac25b | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 20V, Positive-QTOF | splash10-01tc-0219000000-9e4b8f664dbb988d46f0 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 40V, Positive-QTOF | splash10-0540-4594000000-185caf2f40c5027fdb0a | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 10V, Negative-QTOF | splash10-0a4i-0009000000-ba327369eee699ad5a21 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 20V, Negative-QTOF | splash10-0a4l-1019000000-f6f3606b25ff21806842 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 40V, Negative-QTOF | splash10-0pbc-8096000000-deeb08e544bed8419dd5 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 10V, Positive-QTOF | splash10-03di-0019000000-e1f2d66ea30a0f614786 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 20V, Positive-QTOF | splash10-00xr-0079000000-04e603b008124e8b4eed | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 40V, Positive-QTOF | splash10-0a4i-3592000000-3c3bd43e2b935cce0195 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 10V, Negative-QTOF | splash10-0a4i-0019000000-a156d06f21ba3667752f | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 20V, Negative-QTOF | splash10-0kmj-2095000000-57e9fe798f41239f2b23 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aldosterone 40V, Negative-QTOF | splash10-05fs-1091000000-9060d8f84b530afda73b | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | 2020-02-10 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
- Mitochondria
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Fibroblasts
- Intestine
- Kidney
- Lung
- Neuron
- Pancreas
- Placenta
- Platelet
- Skeletal Muscle
- Testis
- Thyroid Gland
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.000139-0.00486 uM | Newborn (0-30 days old) | Female | Normal | | details | Blood | Detected and Quantified | 0.000026 (0.000008 - 0.000044) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00011 (0.000055 - 0.002) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.000194-0.00305 uM | Not Specified | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.00005549-0.000361 uM | Adolescent (13-18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.000282 +/- 0.000037 uM | Elderly (>65 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.000263 +/- 0.000014 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00042 +/- 0.00004 uM | Elderly (>65 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.000055 - 0.000500 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | <0.000444 uM | Not Specified | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.000106-0.000869 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.00002774-0.000444 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.000139-0.00250 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 0.0000010-0.00000666 uM | Not Specified | Female | Normal | | details | Blood | Detected and Quantified | 0.000391-0.00309 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | <0.000860 uM | Not Specified | Not Specified | Normal | | details | Saliva | Detected and Quantified | <1.00 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.01 (0.006-0.014) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.000129-0.00203 umol/mmol creatinine | Newborn (0-30 days old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.000129-0.00407 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0416 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness | | details | Blood | Detected and Quantified | 0.0204-0.0735 uM | Children (1-13 years old) | Female | Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness | | details | Blood | Detected and Quantified | 0.0013 uM | Adolescent (13-18 years old) | Female | Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation | | details | Blood | Detected and Quantified | 0.00041 +/- 0.00005 uM | Adult (>18 years old) | Both | Heart failure | | details | Blood | Detected and Quantified | >0.00333 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 2, Antenatal | | details | Blood | Detected and Quantified | 0.000145-0.00499 uM | Infant (0-1 year old) | Both | Congenital chloride diarrhea | | details | Blood | Detected and Quantified | 0.0000777 uM | Infant (0-1 year old) | Female | Corticosterone methyloxidase I deficiency- CMO I | | details | Blood | Detected and Quantified | 0.000011 uM | Adolescent (13-18 years old) | Female | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | | details | Blood | Detected and Quantified | <0.000069 uM | Adult (>18 years old) | Male | Glucocorticoid resistance | | details | Blood | Detected and Quantified | <0.000069 uM | Infant (0-1 year old) | Female | Lipoid Adrenal Hyperplasia | | details | Blood | Detected and Quantified | 0.000454 uM | Infant (0-1 year old) | Not Specified | Bartter Syndrome, Type 4A, Neonatal, with Sensorineural Deafness | | details | Blood | Detected and Quantified | >0.00415 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 4A, Neonatal, with Sensorineural Deafness | | details | Blood | Detected and Quantified | 0.000233 +/- 0.000040 uM | Adult (>18 years old) | Both | Heart failure | | details | Blood | Detected and Quantified | 0.00361 uM | Newborn (0-30 days old) | Female | Bartter Syndrome, Type 1, Antenatal | | details | Blood | Detected and Quantified | 0.00155 uM | Adult (>18 years old) | Male | Bartter Syndrome, Type 4A, Neonatal, with Sensorineural Deafness | | details | Blood | Detected and Quantified | 0.000128 uM | Newborn (0-30 days old) | Female | Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete | | details | Urine | Detected and Quantified | 0.0000555 umol/mmol creatinine | Infant (0-1 year old) | Female | Lipoid Adrenal Hyperplasia | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Heart failure |
---|
- Ferreira A, Bettencourt P, Pestana M, Correia F, Serrao P, Martins L, Cerqueira-Gomes M, Soares-Da-Silva P: Heart failure, aging, and renal synthesis of dopamine. Am J Kidney Dis. 2001 Sep;38(3):502-9. [PubMed:11532681 ]
| Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency |
---|
- Wong SL, Shu SG, Tsai CR: Seventeen alpha-hydroxylase deficiency. J Formos Med Assoc. 2006 Feb;105(2):177-81. doi: 10.1016/S0929-6646(09)60342-9. [PubMed:16477341 ]
| Bartter Syndrome, Type 4A, Neonatal, with Sensorineural Deafness |
---|
- Zaffanello M, Taranta A, Palma A, Bettinelli A, Marseglia GL, Emma F: Type IV Bartter syndrome: report of two new cases. Pediatr Nephrol. 2006 Jun;21(6):766-70. doi: 10.1007/s00467-006-0090-x. Epub 2006 Apr 1. [PubMed:16583241 ]
- Heilberg IP, Totoli C, Calado JT: Adult presentation of Bartter syndrome type IV with erythrocytosis. Einstein (Sao Paulo). 2015 Oct-Dec;13(4):604-6. doi: 10.1590/S1679-45082015RC3013. Epub 2015 Oct 30. [PubMed:26537508 ]
| Bartter Syndrome, Type 1, Antenatal |
---|
- Adachi M, Asakura Y, Sato Y, Tajima T, Nakajima T, Yamamoto T, Fujieda K: Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1. Endocr J. 2007 Dec;54(6):1003-7. Epub 2007 Nov 12. [PubMed:17998760 ]
| Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete |
---|
- Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL: Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. J Clin Endocrinol Metab. 2008 Mar;93(3):696-702. doi: 10.1210/jc.2007-2330. Epub 2008 Jan 8. [PubMed:18182448 ]
| Bartter Syndrome, Type 2, Antenatal |
---|
- Chan WK, To KF, Tong JH, Law CW: Paradoxical hypertension and salt wasting in Type II Bartter syndrome. Clin Kidney J. 2012 Jun;5(3):217-20. doi: 10.1093/ckj/sfs026. Epub 2012 Mar 29. [PubMed:26069767 ]
| Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness |
---|
- Nozu K, Inagaki T, Fu XJ, Nozu Y, Kaito H, Kanda K, Sekine T, Igarashi T, Nakanishi K, Yoshikawa N, Iijima K, Matsuo M: Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness. J Med Genet. 2008 Mar;45(3):182-6. doi: 10.1136/jmg.2007.052944. [PubMed:18310267 ]
| Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation |
---|
- Igarashi T, Ishii T, Watanabe K, Hayakawa H, Horio K, Sone Y, Ohga K: Persistent isolated proximal renal tubular acidosis--a systemic disease with a distinct clinical entity. Pediatr Nephrol. 1994 Feb;8(1):70-1. [PubMed:8142230 ]
| Congenital chloride diarrhea |
---|
- Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloglu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP: Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19096-101. doi: 10.1073/pnas.0910672106. Epub 2009 Oct 27. [PubMed:19861545 ]
| Corticosterone methyl oxidase I deficiency |
---|
- Ustyol A, Atabek ME, Taylor N, Yeung MC, Chan AO: Corticosterone Methyl Oxidase Deficiency Type 1 with Normokalemia in an Infant. J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):356-9. doi: 10.4274/jcrpe.2824. Epub 2016 Apr 29. [PubMed:27125267 ]
| Glucocorticoid resistance |
---|
- Donner KM, Hiltunen TP, Janne OA, Sane T, Kontula K: Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1. Eur J Endocrinol. 2012 Dec 10;168(1):K9-K18. doi: 10.1530/EJE-12-0532. Print 2013 Jan. [PubMed:23076843 ]
| Lipoid Congenital Adrenal Hyperplasia |
---|
- Fujieda K, Tajima T, Nakae J, Sageshima S, Tachibana K, Suwa S, Sugawara T, Strauss JF 3rd: Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest. 1997 Mar 15;99(6):1265-71. doi: 10.1172/JCI119284. [PubMed:9077535 ]
- Hauffa BP, Miller WL, Grumbach MM, Conte FA, Kaplan SL: Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol (Oxf). 1985 Nov;23(5):481-93. [PubMed:3841304 ]
|
|
---|
Associated OMIM IDs | - 202110 (Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency)
- 602522 (Bartter Syndrome, Type 4A, Neonatal, with Sensorineural Deafness)
- 601678 (Bartter Syndrome, Type 1, Antenatal)
- 613743 (Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete)
- 241200 (Bartter Syndrome, Type 2, Antenatal)
- 613090 (Bartter Syndrome, Type 4B, Neonatal, With Sensorineural Deafness)
- 604278 (Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation)
- 214700 (Congenital chloride diarrhea)
- 203400 (Corticosterone methyl oxidase I deficiency)
- 615962 (Glucocorticoid resistance)
- 201710 (Lipoid Congenital Adrenal Hyperplasia)
|
---|
External Links |
---|
DrugBank ID | DB04630 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB021883 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 5633 |
---|
KEGG Compound ID | C01780 |
---|
BioCyc ID | ALDOSTERONE |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Aldosterone |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5839 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 27584 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | ALDSTRN |
---|
MarkerDB ID | MDB00000018 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Bear, Brian R.; Parnes, Jason S.; Shea, Kenneth J. Progress toward the Total Synthesis of (+)-Aldosterone: Synthesis of the A-D Rings. Organic Letters (2003), 5(10), 1613-1616. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Funder JW: The nongenomic actions of aldosterone. Endocr Rev. 2005 May;26(3):313-21. Epub 2005 Apr 6. [PubMed:15814845 ]
- Shima H, Kawanaka H, Yabumoto Y, Okamoto E, Ikoma F: A case of 17 alpha-hydroxylase deficiency with chromosomal karyotype 46,XY and high plasma aldosterone concentration. Int Urol Nephrol. 1991;23(6):611-8. [PubMed:1769794 ]
- Rosendahl W, Konig M, Haack D, Vecsei P, Lewicka S: [Variability of corticosterone methyl oxidase (type II) deficiency. Presentation of three case reports]. Klin Padiatr. 1993 May-Jun;205(3):180-4. [PubMed:8350592 ]
- Christ M, Zange J, Janson CP, Muller K, Kuklinski P, Schmidt BM, Tillmann HC, Gerzer R, Wehling M: Hypoxia modulates rapid effects of aldosterone on oxidative metabolism in human calf muscle. J Endocrinol Invest. 2001 Sep;24(8):587-97. [PubMed:11686541 ]
- Lijnen P, Petrov V: Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol. 2000 Jun;32(6):865-79. [PubMed:10888242 ]
- du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P: Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Med. 2003 Oct;29(10):1703-9. Epub 2003 Aug 28. [PubMed:14551679 ]
- Laskowska M, Leszczynska-Gorzelak B, Laskowska K, Oleszczuk J: Evaluation of the renin-angiotensin-aldosterone system in pregnancy complicated by preeclampsia with and without intrauterine growth retardation. Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):451-6. [PubMed:16146128 ]
- Few JD, Chaudry S, James VH: The direct determination of aldosterone in human saliva. J Steroid Biochem. 1984 Jul;21(1):87-92. [PubMed:6748658 ]
- Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zeni P, Caruso B, Zardini P: Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2002 Feb 15;89(4):403-7. [PubMed:11835920 ]
- Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ: Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999 Jul;7(4):355-62. [PubMed:10440591 ]
- Lewicka S, Vecsei P, Bige K, Fisher T, Winter J, Abdelhamid S, Heinrich U, Bokkenheuser VD: Urinary excretion of aldosterone metabolite Kelly-M1 in patients with adrenal dysfunction. J Steroid Biochem. 1988 Mar;29(3):333-9. [PubMed:3258645 ]
- Heindl S, Holzschneider J, Hinz A, Sayk F, Fehm HL, Dodt C: Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans. J Neuroendocrinol. 2006 Feb;18(2):115-21. [PubMed:16420280 ]
- Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM: Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005 Mar;45(3):356-62. Epub 2005 Jan 3. [PubMed:15630041 ]
- Velazquez H, Perazella MA, Wright FS, Ellison DH: Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993 Aug 15;119(4):296-301. [PubMed:8328738 ]
- Touger L, Joseph M, Hasan KS: Hypertension in a patient with aldosterone deficiency. Endocr Pract. 2005 Mar-Apr;11(2):104-7. [PubMed:15901525 ]
- Summa V, Camargo SM, Bauch C, Zecevic M, Verrey F: Isoform specificity of human Na(+), K(+)-ATPase localization and aldosterone regulation in mouse kidney cells. J Physiol. 2004 Mar 1;555(Pt 2):355-64. Epub 2003 Dec 23. [PubMed:14694143 ]
- Fox CS, Larson MG, Hwang SJ, Leip EP, Rifai N, Levy D, Benjamin EJ, Murabito JM, Meigs JB, Vasan RS: Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int. 2006 Jun;69(11):2064-9. [PubMed:16572107 ]
- Badalian SS, Mikhailov AV: [Characteristics of the renin-aldosterone system of the fetoplacental complex in fetal erythroblastosis]. Akush Ginekol (Mosk). 1990 May;(5):55-8. [PubMed:2118736 ]
- Tanemoto M, Abe T, Obara N, Abe M, Satoh F, Ito S: Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker. Hypertens Res. 2003 Oct;26(10):863-8. [PubMed:14621191 ]
- Pitt B, Stier CT Jr, Rajagopalan S: Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2003 Sep;4(3):164-8. [PubMed:14608520 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|